So far, we have to know about the positive applications of these therapies that are being transplanted into the body with living cells to be treated, or eliminated from the body of the patient. A hematopoietic therapy is the most common form of cell therapy. It is a well-known cell-based therapy obtained from the donor ‘s body for the recipient to produce bone marrow, with its self-renewal and differentiation capabilities into many cell types.Learn more about us at Commerce Chiropractor
Stem cell-based therapies have the potential to treat various disorders , especially those linked to the blood and immune system. A broad variety of these therapies including allogeneic cell therapies, autologous therapies, and mesenchymal therapies have shown substantial breakthroughs in clinical trials to treat many medical conditions such as arthritis, spinal cord injury, diabetes and strokes. More recently, we have the blessing of induced pluripotent stem cells which have the same characteristic as adult embryonic stem cells which can be cultivated to create embryonic stem cells. For another main purpose- tissue engineering these cells are essential.
Cell therapies have achieved medical and economic advances over the last few decades to develop as a novel therapeutic alternative for many cellular dysfunctional illnesses. If statistics are to be believed, by 2009 the global stem cell therapy industry had reached an annual revenue of $410 million, and the industry was projected to increase and hit a total of 100 million people in the Future.
And medical companies and research institutes want to move their clinical applications from bench to bedside due to its various medical benefits.
While we are subject to several disputes and debates, we have ample evidence to prove that therapy is indeed an efficient therapeutic method for treating a variety of diseases, including cosmetic procedures such as hair regrowth, skin redefinition and so on.
Besides that, the the number of cell-based clinical trails hold true to the potential for stem cell efficiencies and their applications. A new report as of June 2010 illustrated cell therapy capabilities across 2000 (approx.) clinical biomedical research trials.
Although manipulation of embryonic cells is limited and contentious, a greater chance of developing iPSC engineered tissues is viable under extreme conditions for medical interventions. And that’s the fundamental reason why the public and community are seeking more clinical trials of stem cell-based therapies and their medical applications.
It is therefore important to commercialise the use of stem cells for the rapid development of biomedical research, and through knowledge enhance public health. Some important aspects of stem cell therapy commercialisation are as follows.
Commercialization promotes the advancement of new technology and intellectual property for some stem cell research, growing its importance in the therapeutic market.
It seeks to promote both economic growth and enhance public health.
It supports grants or funds to be used in clinical research to produce treatments and goods that are more economically competitive on the market.
It is also essential that public information is translated.